Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6132
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
RASILEZ HCT 150MG/25MG TBL FLM 90(3X30) I
0500998 EU/1/08/491/027 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 150MG/25MG TBL FLM 98(2X49) I
0500999 EU/1/08/491/028 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 150MG/25MG TBL FLM 280(20X14) I
0501000 EU/1/08/491/029 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 150MG/25MG TBL FLM 56X1 II
0500466 EU/1/08/491/036 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 150MG/25MG TBL FLM 90 II
0500467 EU/1/08/491/037 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 150MG/25MG TBL FLM 98 II
0500468 EU/1/08/491/038 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 150MG/25MG TBL FLM 98(2X49X1) II
0500469 EU/1/08/491/039 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 150MG/25MG TBL FLM 280(20X14) II
0500470 EU/1/08/491/040 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 7 I
0500471 EU/1/08/491/041 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 14 I
0500472 EU/1/08/491/042 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 28 I
0500473 EU/1/08/491/043 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 30 I
0500474 EU/1/08/491/044 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 50 I
0500475 EU/1/08/491/045 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 56 I
0500476 EU/1/08/491/046 rasilezhct.pdf rasilezhct.pdf C09XA52 R
REVERANTZA 40MG/5MG TBL FLM 28
0240672 58/ 055/19-C reverantza.pdf reverantza.pdf C09DB02 R
REVERANTZA 20MG/5MG TBL FLM 14
0263170 58/ 054/19-C reverantza.pdf reverantza.pdf C09DB02 R
REVERANTZA 40MG/5MG TBL FLM 14
0263171 58/ 055/19-C reverantza.pdf reverantza.pdf C09DB02 R
REVERANTZA 20MG/5MG TBL FLM 28
0240670 58/ 054/19-C reverantza.pdf reverantza.pdf C09DB02 R
REVERANTZA 20MG/5MG TBL FLM 30
0240671 58/ 054/19-C reverantza.pdf reverantza.pdf C09DB02 R
REVERANTZA 40MG/5MG TBL FLM 30
0240673 58/ 055/19-C reverantza.pdf reverantza.pdf C09DB02 R

‹‹ ‹ 100 150 160 170 180 190 191 192 193 194 195 196 197 198 199 200 201 210 220 230 240 250 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 25. January 2022 at 00:10
Last update of price and payment data: 1. January 2022 at 00:11